What is the recommended steroid replacement therapy regimen after resection of an Adrenocorticotropic hormone (ACTH) secreting tumor?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Steroid Replacement Therapy After ACTH-Secreting Tumor Resection

After resection of an ACTH-secreting tumor, patients should receive hydrocortisone 100 mg intravenously at induction, followed by a continuous infusion of 200 mg/24 hours while nil by mouth, then transition to double the normal oral hydrocortisone dose for 48 hours or up to a week following major surgery. 1

Pathophysiology and Rationale

The removal of an ACTH-secreting tumor results in sudden withdrawal of excessive ACTH stimulation to the adrenal glands, which can lead to adrenal insufficiency. During the period of tumor presence:

  • The hypothalamic-pituitary-adrenal (HPA) axis was suppressed due to excess ACTH and cortisol
  • Normal corticotrophs in the pituitary were inhibited
  • The contralateral adrenal gland may have atrophied

This creates a high risk for acute adrenal insufficiency post-operatively, which can be life-threatening if not properly managed.

Immediate Post-Operative Management

For the immediate post-operative period:

  • Administer hydrocortisone 100 mg intravenously on induction 1
  • Follow with continuous infusion of hydrocortisone 200 mg/24 hours 1
  • Alternative: hydrocortisone 50 mg every 6 hours by intramuscular injection 1
  • Continue this regimen while the patient is nil by mouth or experiencing post-operative vomiting 1

Transition to Oral Therapy

When the patient can take oral medications:

  • Double the normal hydrocortisone replacement dose for 48 hours 1
  • For major surgery, continue double dosing for up to a week 1
  • Typical maintenance dose ranges from 15-25 mg/day in divided doses 2
  • Common dosing schedule: 10 mg (morning) + 5 mg (noon) + 2.5 mg (afternoon) 2

Long-Term Management

After the initial post-operative period:

  • Continue steroid replacement until recovery of the HPA axis 1
  • Monitor morning cortisol levels to assess recovery
  • A morning cortisol ≥8 μg/dl can indicate adequate adrenal function 3
  • Recovery of the HPA axis may take months to years, and some patients may require lifelong replacement

Monitoring for Recovery

To assess recovery of the HPA axis:

  • Check morning cortisol levels (8:00 AM) at regular intervals
  • A cut-off value of 8 μg/dl can be used to evaluate HPA status 3
  • Consider low-dose (1 μg) ACTH stimulation test at 6 weeks and repeat at 12 months 3
  • Signs of over-replacement: weight gain, insomnia, peripheral edema 2
  • Signs of under-replacement: lethargy, nausea, poor appetite, weight loss 2

Special Considerations

  • All patients should receive medical alert identification indicating adrenal insufficiency 2
  • Patient education on stress dosing is essential:
    • Minor illness with fever <38°C: double oral dose 2
    • Moderate illness with fever >38°C: triple oral dose 2
    • Severe illness or surgery: 100 mg hydrocortisone IV/IM before procedure, then every 6 hours 2

Common Pitfalls to Avoid

  • Failure to provide adequate steroid coverage during the immediate post-operative period
  • Tapering steroids too quickly before HPA axis recovery
  • Not educating patients about stress dosing and emergency management
  • Overlooking signs of adrenal insufficiency: hypotension, hyponatremia, hyperkalemia, hypoglycemia
  • Not providing patients with emergency injectable hydrocortisone and instructions for use

Important Note

The need for steroid replacement is universal in patients with Cushing syndrome from ACTH-secreting tumors. In a study of 331 consecutive adrenalectomies, all patients with Cushing syndrome required steroid replacement therapy post-operatively 4. Failure to provide adequate steroid coverage can result in life-threatening adrenal crisis.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hydrocortisone Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.